{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-26-031671","form_type":"8-K","ticker":"GRCE","cik":"0001444192","company_name":"Grace Therapeutics, Inc.","filed_at":"2026-08-06T20:06:10+00:00","discovered_at":"2026-08-06T20:08:02.430271+00:00","generated_at":"2026-08-06T20:08:43.367653+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.55,"calibrated_materiality_score":0.55,"confidence":"high","headline":"Grace Therapeutics raises $10M in private placement; extends cash runway to end of 2028","bullets":["Issued 4,761,904 shares at $2.10/share for gross proceeds of $10M; closed August 6, 2026.","Net proceeds plus existing cash expected to extend cash runway to end of calendar 2028.","Dual-source manufacturing strategy for GTx-104 initiated; NDA resubmission timing depends on manufacturing readiness.","Technology transfer to a U.S.-based contract manufacturer is underway.","Craig-Hallum acted as sole placement agent for the private placement."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-26-031671","json":"https://secwatch.observer/filing/0001140361-26-031671.json","markdown":"https://secwatch.observer/filing/0001140361-26-031671.md","text":"https://secwatch.observer/filing/0001140361-26-031671.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1444192/000114036126031671/0001140361-26-031671-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1444192/000114036126031671/ef20079559_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-08-06T20:08:43.367653+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}